The federal Food & Drug Administration has approved two new Alzheimer’s medications that can offer people more time to live ...

Australia is unlikely to follow the UK’s lead in formalising a ban on the use of puberty blockers for young people with ...

Personalised vaccines being trialled for bowel cancer patients are a "really big advance", a senior consultant at a leading ...

The ability of artificial intelligence to quickly analyse huge data sets is revolutionising expensive and time-consuming ...

IQVIA has better operating margins, operational efficiency, strong cash flows, and moderate leverage. See why IQV stock is a ...

Press Release - An impact-driven, outcome-guided, priority-based, and ethically conducted health research agenda in Africa urgently needs a standardised approach to health research prioritisation, a ...

The government has decided that all imports of rare drugs will be facilitated, with samples of rare disease drugs tested on ...

An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Cardiff Oncology plans to share additional clinical data from its onvansertib trial in the first half of 2025.

A new clinical study being done at UCSF could change the way doctors treat patients with traumatic brain injuries.

FemPulse announced today that it received FDA investigational device exemption (IDE) approval for its overactive bladder (OAB ...